The only diagnostic and prognostic biomarker validated so far is alpha-fetoprotein (AFP), while osteopontin and glypican-3 are currently under investigation for the early diagnosis of HCC [19]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.